참고문헌
- Achour, M., Le Gras, S., Keime, C., Parmentier, F., Lejeune, F.X., Boutillier, A.L., Neri, C., Davidson, I., and Merienne, K. (2015). Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice. Hum. Mol. Genet. 24, 3481-3496. https://doi.org/10.1093/hmg/ddv099
- Adam, R.C., Yang, H., Rockowitz, S., Larsen, S.B., Nikolova, M., Oristian, D.S., Polak, L., Kadaja, M., Asare, A., Zheng, D., et al. (2015). Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521, 366-370. https://doi.org/10.1038/nature14289
- Amorim, S., Stathis, A., Gleeson, M., Iyengar, S., Magarotto, V., Leleu, X., Morschhauser, F., Karlin, L., Broussais, F., Rezai, K., et al. (2016). Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. Lancet Haematol. 3, e196-204. https://doi.org/10.1016/S2352-3026(16)00021-1
- Banerji, J., Rusconi, S., and Schaffner, W. (1981). Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27, 299-308. https://doi.org/10.1016/0092-8674(81)90413-X
- Banerji, J., Olson, L., and Schaffner, W. (1983). A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33, 729-740. https://doi.org/10.1016/0092-8674(83)90015-6
- Carter, D., Chakalova, L., Osborne, C.S., Dai, Y.F., and Fraser, P. (2002). Long-range chromatin regulatory interactions in vivo. Nat. Genet. 32, 623-626. https://doi.org/10.1038/ng1051
- Cavalli, G., Hayashi, M., Jin, Y., Yorgov, D., Santorico, S.A., Holcomb, C., Rastrou, M., Erlich, H., Tengesdal, I.W., Dagna, L., et al. (2016). MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proc. Natl. Acad. Sci. USA 113, 1363-1368. https://doi.org/10.1073/pnas.1523482113
- Chipumuro, E., Marco, E., Christensen, C.L., Kwiatkowski, N., Zhang, T., Hatheway, C.M., Abraham, B.J., Sharma, B., Yeung, C., Altabef, A., et al. (2014). CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 159, 1126-1139. https://doi.org/10.1016/j.cell.2014.10.024
- Christensen, C.L., Kwiatkowski, N., Abraham, B.J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G.S., Akbay, E.A., Altabef, A., et al. (2014). Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell 26, 909-922. https://doi.org/10.1016/j.ccell.2014.10.019
- Dowen, J.M., Fan, Z.P., Hnisz, D., Ren, G., Abraham, B.J., Zhang, L.N., Weintraub, A.S., Schujiers, J., Lee, T.I., Zhao, K., et al. (2014). Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 159, 374-387. https://doi.org/10.1016/j.cell.2014.09.030
- Drier, Y., Cotton, M.J., Williamson, K.E., Gillespie, S.M., Ryan, R.J., Kluk, M.J., Carey, C.D., Rodig, S.J., Sholl, L.M., Afrogheh, A.H., et al. (2016). An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat. Genet. 48, 265-272. https://doi.org/10.1038/ng.3502
- Groschel, S., Sanders, M.A., Hoogenboezem, R., de Wit, E., Bouwman, B.A.M., Erpelinck, C., van der Velden, V.H.J., Havermans, M., Avellino, R., van Lom, K., et al. (2014). A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157, 369-381. https://doi.org/10.1016/j.cell.2014.02.019
- Hay, D., Hughes, J.R., Babbs, C., Davies, J.O.J., Graham, B.J., Hanssen, L., Kassouf, M.T., Marieke Oudelaar, A.M., Sharpe, J.A., Suciu, M.C., et al. (2016). Genetic dissection of the alpha-globin super-enhancer in vivo. Nat. Genet. 48, 895-903. https://doi.org/10.1038/ng.3605
- Heinz, S., Romanoski, C.E., Benner, C., and Glass, C.K. (2015). The selection and function of cell type-specific enhancers. Nat. Rev. Mol. Cell Biol. 16, 144-154. https://doi.org/10.1038/nrm3949
- Henssen, A., Althoff, K., Odersky, A., Beckers, A., Koche, R., Speleman, F., Schafers, S., Bell, E., Nortmeyer, M., Westermann, F., et al. (2016). Targeting MYCN-driven transcription by BETbromodomain inhibition. Clin. Cancer Res. 22, 2470-2481. https://doi.org/10.1158/1078-0432.CCR-15-1449
- Herz, H.M., Hu, D., and Shilatifard, A. (2014). Enhancer malfunction in cancer. Mol. Cell 53, 859-866. https://doi.org/10.1016/j.molcel.2014.02.033
- Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre, V., Sigova, A.A., Hoke, H.A., and Young, R.A. (2013). Super-enhancers in the control of cell identity and disease. Cell 155, 934-947. https://doi.org/10.1016/j.cell.2013.09.053
- Huang, J., Liu, X., Li, D., Shao, Z., Cao, H., Zhang, Y., Trompouki, E., Bowman, T.V., Zon, L.I., Yuan, G.C., et al. (2016). Dynamic control of enhancer repertoires drives lineage and stage-specific transcription during hematopoiesis. Dev. Cell 36, 9-23. https://doi.org/10.1016/j.devcel.2015.12.014
- Jiang, Y.Y., Lin, D.C., Mayakonda, A., Hazawa, M., Ding, L.W., Chien, W.W., Xu, L., Chen, Y., Xiao, J.F., Senapedis, W., et al. (2017). Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Gut 66, 1358-1368. https://doi.org/10.1136/gutjnl-2016-311818
- Jiao, W., Chen, Y., Song, H., Li, D., Mei, H., Yang, F., Fang, E., Wang, X., Huang, K., Zheng, L., et al. (2018). HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis. Oncogene [Epub ahead of print].
- Kagey, M.H., Newman, J.J., Bilodeau, S., Zhan, Y., Orlando, D.A., van Berkum, N.L., Ebmeier, C.C., Goossens, J., Rahl, P.B., Levine, S.S., et al. (2010). Mediator and cohesin connect gene expression and chromatin architecture. Nature 467, 430-435. https://doi.org/10.1038/nature09380
- Katerndahl, C.D.S., Heltemes-Harris, L.M., Willette, M.J.L., Henzler, C.M., Frietze, S., Yang, R., Schjerven, H., Silverstein, K.A.T., Ramsey, L.B., Hubbard, G., et al. (2017). Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nat Immunol 18, 694-704. https://doi.org/10.1038/ni.3716
- Kennedy, A.L., Vallurupalli, M., Chen, L., Crompton, B., Cowley, G., Vazquez, F., Weir, B.A., Tsherniak, A., Parasuraman, S., Kim, S., et al. (2015). Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget 6, 30178-30193.
- Kim, T.K., Hemberg, M., Gray, J.M., Costa, A.M., Bear, D.M., Wu, J., Harmin, D.A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2010). Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187. https://doi.org/10.1038/nature09033
- Ko, J.Y., Oh, S., and Yoo, K.H. (2017). Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development. Mol. Cells 40, 169-177.
- Kulaeva, O.I., Nizovtseva, E.V., Polikanov, Y.S., Ulianov, S.V. and Studitsky, V.M. (2012). Distant activation of transcription: mechanisms of enhancer action. Mol. Cell Biol. 32, 4892-4897. https://doi.org/10.1128/MCB.01127-12
- Kwiatkowski, N., Zhang, T., Rahl, P.B., Abraham, B.J., Reddy, J., Ficarro, S.B., Dastur, A., Amzallag, A., Ramaswamy, S., Tesar, B., et al. (2014). Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 511, 616-620. https://doi.org/10.1038/nature13393
- Le Gras, S., Keime, C., Anthony, A., Lotz, C., De Longprez, L., Brouillet, E., Cassel, J.C., Boutillier, A.L. and Merienne, K. (2017). Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature. Sci. Rep. 7, 42875. https://doi.org/10.1038/srep42875
- Lee, H.K., Willi, M., Wang, C., Yang, C.M., Smith, H.E., Liu, C., and Hennighausen, L. (2017). Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice. Nucleic Acids Res. 45, 4606-4618. https://doi.org/10.1093/nar/gkx185
- Levine, M. (2010). Transcriptional enhancers in animal development and evolution. Curr. Biol. 20, R754-763. https://doi.org/10.1016/j.cub.2010.06.070
- Levine, M., Cattoglio, C., and Tjian, R. (2014). Looping back to leap forward: transcription enters a new era. Cell 157, 13-25. https://doi.org/10.1016/j.cell.2014.02.009
- Li, Y., Rivera, C.M., Ishii, H., Jin, F., Selvaraj, S., Lee, A.Y., Dixon, J.R., and Ren, B. (2014). CRISPR reveals a distal super-enhancer required for Sox2 expression in mouse embryonic stem cells. PLoS One 9, e114485. https://doi.org/10.1371/journal.pone.0114485
- Liang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K.M., Kieff, E., and Zhao, B. (2016). Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc. Natl. Acad. Sci. USA 113, 14121-14126. https://doi.org/10.1073/pnas.1616697113
- Loven, J., Hoke, H.A., Lin, C.Y., Lau, A., Orlando, D.A., Vakoc, C.R., Bradner, J.E., Lee, T.I., and Young, R.A. (2013). Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320-334. https://doi.org/10.1016/j.cell.2013.03.036
- Mansour, M.R., Abraham, B.J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A.D., Etchin, J., Lawton, L., Sallan, S.E., Silverman, L.B., et al. (2014). Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346, 1373-1377. https://doi.org/10.1126/science.1259037
- Northcott, P.A., Lee, C., Zichner, T., Stutz, A.M., Erkek, S., Kawauchi, D., Shih, D.J., Hovestadt, V., Zapatka, M., Sturm, D., et al. (2014). Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428-434. https://doi.org/10.1038/nature13379
- Oldridge, D.A., Wood, A.C., Weichert-Leahey, N., Crimmins, I., Sussman, R., Winter, C., McDaniel, L.D., Diamond, M., Hart, L.S., Zhu, S., et al. (2015). Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature 528, 418-421. https://doi.org/10.1038/nature15540
- Ong, C.T., and Corces, V.G. (2011). Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 12, 283-293.
- Ong, C.T., and Corces, V.G. (2012). Enhancers: emerging roles in cell fate specification. EMBO Rep. 13, 423-430. https://doi.org/10.1038/embor.2012.52
- Parker, S.C., Stitzel, M.L., Taylor, D.L., Orozco, J.M., Erdos, M.R., Akiyama, J.A., van Bueren, K.L., Chines, P.S., Narisu, N., Program, N.C.S., et al. (2013). Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. USA 110, 17921-17926. https://doi.org/10.1073/pnas.1317023110
- Peeters, J.G., Vervoort, S.J., Tan, S.C., Mijnheer, G., de Roock, S., Vastert, S.J., Nieuwenhuis, E.E., van Wijk, F., Prakken, B.J., Creyghton, M.P., et al. (2015). Inhibition of super-enhancer activity in autoinflammatory site-derived T cells reduces disease-associated gene expression. Cell Rep. 12, 1986-1996. https://doi.org/10.1016/j.celrep.2015.08.046
- Pefanis, E., Wang, J., Rothschild, G., Lim, J., Kazadi, D., Sun, J., Federation, A., Chao, J., Elliott, O., Liu, Z.P., et al. (2015). RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell 161, 774-789. https://doi.org/10.1016/j.cell.2015.04.034
- Pelish, H.E., Liau, B.B., Nitulescu, II, Tangpeerachaikul, A., Poss, Z.C., Da Silva, D.H., Caruso, B.T., Arefolov, A., Fadeyi, O., Christie, A.L., et al. (2015). Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature 526, 273-276. https://doi.org/10.1038/nature14904
- Pott, S. and Lieb, J.D. (2015). What are super-enhancers? Nat Genet 47, 8-12. https://doi.org/10.1038/ng.3167
- Sengupta, S., and George, R.E. (2017). Super-enhancer-driven transcriptional dependencies in cancer. Trends Cancer 3, 269-281. https://doi.org/10.1016/j.trecan.2017.03.006
- Sengupta, D., Kannan, A., Kern, M., Moreno, M.A., Vural, E., Stack, B., Jr., Suen, J.Y., Tackett, A.J. and Gao, L. (2015). Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics 10, 460-466. https://doi.org/10.1080/15592294.2015.1034416
- Shi, J., Whyte, W.A., Zepeda-Mendoza, C.J., Milazzo, J.P., Shen, C., Roe, J.S., Minder, J.L., Mercan, F., Wang, E., Eckersley-Maslin, M.A., et al. (2013). Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 27, 2648-2662. https://doi.org/10.1101/gad.232710.113
- Shin, H.Y., Willi, M., Yoo, K.H., Zeng, X., Wang, C., Metser, G., and Hennighausen, L. (2016). Hierarchy within the mammary STAT5-driven Wap super-enhancer. Nat Genet 48, 904-911. https://doi.org/10.1038/ng.3606
- Shlyueva, D., Stampfel, G., and Stark, A. (2014). Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272-286. https://doi.org/10.1038/nrg3682
- Siersbaek, R., Rabiee, A., Nielsen, R., Sidoli, S., Traynor, S., Loft, A., La Cour Poulsen, L., Rogowska-Wrzesinska, A., Jensen, O.N., and Mandrup, S. (2014). Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep. 7, 1443-1455. https://doi.org/10.1016/j.celrep.2014.04.042
- Tolhuis, B., Palstra, R.J., Splinter, E., Grosveld, F., and de Laat, W. (2002). Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10, 1453-1465. https://doi.org/10.1016/S1097-2765(02)00781-5
- Vahedi, G., Kanno, Y., Furumoto, Y., Jiang, K., Parker, S.C., Erdos, M.R., Davis, S.R., Roychoudhuri, R., Restifo, N.P., Gadina, M., et al. (2015). Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 520, 558-562. https://doi.org/10.1038/nature14154
- Walker, B.A., Wardell, C.P., Brioli, A., Boyle, E., Kaiser, M.F., Begum, D.B., Dahir, N.B., Johnson, D.C., Ross, F.M., Davies, F.E., et al. (2014). Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients. Blood Cancer J 4, e191. https://doi.org/10.1038/bcj.2014.13
- Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I., and Young, R.A. (2013). Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-319. https://doi.org/10.1016/j.cell.2013.03.035
- Willi, M., Yoo, K.H., Reinisch, F., Kuhns, T.M., Lee, H.K., Wang, C., and Hennighausen, L. (2017). Facultative CTCF sites moderate mammary super-enhancer activity and regulate juxtaposed gene in non-mammary cells. Nat. Commun. 8, 16069. https://doi.org/10.1038/ncomms16069
- Wong, R.W.J., Ngoc, P.C.T., Leong, W.Z., Yam, A.W.Y., Zhang, T., Asamitsu, K., Iida, S., Okamoto, T., Ueda, R., Gray, N.S., et al. (2017). Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Blood 130, 2326-2338 https://doi.org/10.1182/blood-2017-06-792184
- Wyce, A., Ganji, G., Smitheman, K.N., Chung, C.W., Korenchuk, S., Bai, Y., Barbash, O., Le, B., Craggs, P.D., McCabe, M.T., et al. (2013). BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models. PLoS One 8, e72967. https://doi.org/10.1371/journal.pone.0072967
- Yin, J.W., and Wang, G. (2014). The Mediator complex: a master coordinator of transcription and cell lineage development. Development 141, 977-987. https://doi.org/10.1242/dev.098392
- Yokoyama, Y., Zhu, H., Lee, J.H., Kossenkov, A.V., Wu, S.Y., Wickramasinghe, J.M., Yin, X., Palozola, K.C., Gardini, A., Showe, L.C., et al. (2016). BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer. Cancer Res 76, 6320-6330. https://doi.org/10.1158/0008-5472.CAN-16-0854
- Zeng, L., and Zhou, M.M. (2002). Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 513, 124-128. https://doi.org/10.1016/S0014-5793(01)03309-9
- Zhang, X., Choi, P.S., Francis, J.M., Imielinski, M., Watanabe, H., Cherniack, A.D., and Meyerson, M. (2016). Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat. Genet. 48, 176-182. https://doi.org/10.1038/ng.3470
피인용 문헌
- Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing pp.1573-7039, 2018, https://doi.org/10.1007/s10911-018-9417-z
- Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment vol.10, pp.None, 2018, https://doi.org/10.3389/fphar.2019.00361
- Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective vol.126, pp.None, 2018, https://doi.org/10.1016/j.yjmcc.2018.10.024
- The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers vol.41, pp.3, 2019, https://doi.org/10.1007/s13258-018-0768-z
- Dysregulated Transcriptional Control in Prostate Cancer vol.20, pp.12, 2019, https://doi.org/10.3390/ijms20122883
- In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma vol.20, pp.14, 2019, https://doi.org/10.3390/ijms20143582
- Bromodomains: a new target class for drug development vol.18, pp.8, 2019, https://doi.org/10.1038/s41573-019-0030-7
- Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure vol.24, pp.5, 2018, https://doi.org/10.1007/s10741-019-09792-3
- Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity vol.33, pp.11, 2019, https://doi.org/10.1038/s41375-019-0474-0
- Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation vol.20, pp.suppl10, 2018, https://doi.org/10.1186/s12864-019-6293-x
- Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington’s disease vol.116, pp.49, 2019, https://doi.org/10.1073/pnas.1908113116
- Super-enhancers in transcriptional regulation and genome organization vol.47, pp.22, 2019, https://doi.org/10.1093/nar/gkz1038
- Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases vol.8, pp.None, 2018, https://doi.org/10.3389/fcell.2020.00534
- The Klf6 Super-enhancer Determines Klf6 Sensitivity to BRD4 Inhibitors in Human Hepatoma (HepG2) Cells vol.9, pp.None, 2020, https://doi.org/10.2174/2211550109999200802154246
- Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines vol.21, pp.5, 2018, https://doi.org/10.3390/ijms21051630
- Epigenetic Targeting of TERT-Associated Gene Expression Signature in Human Neuroblastoma with TERT Overexpression vol.80, pp.5, 2018, https://doi.org/10.1158/0008-5472.can-19-2560
- Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease vol.12, pp.554, 2020, https://doi.org/10.1126/scitranslmed.aba3613
- Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease vol.2, pp.8, 2018, https://doi.org/10.1038/s42255-020-0227-4
- Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer vol.52, pp.9, 2020, https://doi.org/10.1038/s12276-020-00493-8
- A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer vol.38, pp.5, 2018, https://doi.org/10.1016/j.ccell.2020.08.020
- Identification of Potential Pathogenic Super-Enhancers-Driven Genes in Pulmonary Fibrosis vol.12, pp.None, 2021, https://doi.org/10.3389/fgene.2021.644143
- Targeting MYCN in Pediatric and Adult Cancers vol.10, pp.None, 2018, https://doi.org/10.3389/fonc.2020.623679
- Identification of Novel Genetic Regulatory Region for Proprotein Convertase FURIN and Interferon Gamma in T Cells vol.12, pp.None, 2018, https://doi.org/10.3389/fimmu.2021.630389
- CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers vol.13, pp.12, 2018, https://doi.org/10.3390/cancers13122872
- Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma vol.12, pp.8, 2021, https://doi.org/10.1038/s41419-021-04060-5
- Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis vol.12, pp.1, 2018, https://doi.org/10.1038/s41467-021-24843-w